Abstract
Aims: Our study aimed to investigate the function of GALNT2 in lung adenocarcinoma (LUAD). Main methods: We used network tools and tissue microarray immunohistochemistry to measure the expression levels of GALNT2 in LUAD. Kaplan-Meier curves and Cox regression methods were used in survival analysis. We detected the role of GALNT2 in cell lines by Cell Counting Kit-8, colony formation, transwell, and wound healing assays. We performed Western blotting to evaluate downstream protein levels. Key findings: GALNT2 was highly expressed in LUAD samples and indicated a poor prognosis. Knockdown of GALNT2 suppressed cell line proliferation, migration, and invasion abilities, while overexpression of GALNT2 enhanced those phenotypes. Moreover, GALNT2 activated Notch/Hes1-PTEN-PI3K/Akt signaling axis. Significance: Our data confirmed the cancer-promoting effect of GALNT2, and might provide a new approach for LUAD therapy.
| Original language | English |
|---|---|
| Article number | 119439 |
| Journal | Life Sciences |
| Volume | 276 |
| DOIs | |
| State | Published - 1 Jul 2021 |
| Externally published | Yes |
Keywords
- GALNT2
- Lung adenocarcinoma
- Metastasis
- Notch
- Proliferation